Thilo Jakob to Middle Aged
This is a "connection" page, showing publications Thilo Jakob has written about Middle Aged.
Connection Strength
0.016
-
The global impact of the COVID-19 pandemic on the management and course of chronic urticaria. Allergy. 2021 03; 76(3):816-830.
Score: 0.004
-
Generalized reactions during skin testing with clindamycin in drug hypersensitivity: a report of 3 cases and review of the literature. Contact Dermatitis. 2018 Apr; 78(4):274-280.
Score: 0.003
-
Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial. J Allergy Clin Immunol. 2017 09; 140(3):870-873.e5.
Score: 0.003
-
H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study. Clin Exp Allergy. 2017 May; 47(5):684-692.
Score: 0.003
-
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol. 2013 Jul; 132(1):101-9.
Score: 0.002
-
Association of NOD1 polymorphisms with atopic eczema and related phenotypes. J Allergy Clin Immunol. 2005 Jul; 116(1):177-84.
Score: 0.001